Jointown Pharmaceutical Group Co., Ltd. Provides Earnings Guidance for the Year 2017
January 28, 2018
Share
Jointown Pharmaceutical Group Co., Ltd. provided earnings guidance for the year 2017. According to preliminary statistics of its financial department, the company predicts the net profit owned by shareholders of the company in 2017 to be between RMB 1,403.7 million and RMB 1,490.7 million, a year-on-year increase of between RMB 526.96 million and RMB 613.96 million, as well as a year-on-year increase between 60% and 70%. The net profit belonging to shareholders of the company after excluding extraordinary profit and loss will be between RMB 991.7 million and RMB 1,057.7 million, a year-on-year increase of between RMB 165.96 million and RMB 231.96 million, a year-on-year increase of between 20% and 28%.
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.